vs

Side-by-side financial comparison of Frontdoor, Inc. (FTDR) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

Frontdoor, Inc. is the larger business by last-quarter revenue ($451.0M vs $270.8M, roughly 1.7× HUTCHMED (China) Ltd). Frontdoor, Inc. runs the higher net margin — 9.1% vs 0.7%, a 8.4% gap on every dollar of revenue. On growth, Frontdoor, Inc. posted the faster year-over-year revenue change (5.9% vs -16.5%). Frontdoor, Inc. produced more free cash flow last quarter ($114.0M vs $3.4M).

Frontdoor, Inc. operates a leading U.S.-focused home services and protection platform. It offers customizable home warranty plans covering repairs and replacements for household appliances, HVAC, plumbing, and electrical systems, plus on-demand access to a network of pre-vetted local service professionals for residential maintenance and repairs.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

FTDR vs HCM — Head-to-Head

Bigger by revenue
FTDR
FTDR
1.7× larger
FTDR
$451.0M
$270.8M
HCM
Growing faster (revenue YoY)
FTDR
FTDR
+22.4% gap
FTDR
5.9%
-16.5%
HCM
Higher net margin
FTDR
FTDR
8.4% more per $
FTDR
9.1%
0.7%
HCM
More free cash flow
FTDR
FTDR
$110.6M more FCF
FTDR
$114.0M
$3.4M
HCM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FTDR
FTDR
HCM
HCM
Revenue
$451.0M
$270.8M
Net Profit
$41.0M
$2.0M
Gross Margin
55.0%
37.7%
Operating Margin
-13.2%
Net Margin
9.1%
0.7%
Revenue YoY
5.9%
-16.5%
Net Profit YoY
10.8%
-83.6%
EPS (diluted)
$0.57
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FTDR
FTDR
HCM
HCM
Q1 26
$451.0M
Q4 25
$432.0M
$270.8M
Q3 25
$618.0M
Q2 25
$617.0M
$277.7M
Q1 25
$426.0M
$324.5M
Q4 24
$383.0M
Q3 24
$540.0M
Q2 24
$542.0M
$305.7M
Net Profit
FTDR
FTDR
HCM
HCM
Q1 26
$41.0M
Q4 25
$1.0M
$2.0M
Q3 25
$106.0M
Q2 25
$111.0M
$455.0M
Q1 25
$37.0M
$11.9M
Q4 24
$9.0M
Q3 24
$100.0M
Q2 24
$92.0M
$25.8M
Gross Margin
FTDR
FTDR
HCM
HCM
Q1 26
55.0%
Q4 25
49.3%
37.7%
Q3 25
57.1%
Q2 25
57.7%
0.1%
Q1 25
55.2%
48.0%
Q4 24
48.0%
Q3 24
56.7%
Q2 24
56.5%
41.1%
Operating Margin
FTDR
FTDR
HCM
HCM
Q1 26
Q4 25
0.5%
-13.2%
Q3 25
23.0%
Q2 25
23.7%
-1.3%
Q1 25
11.3%
-5.0%
Q4 24
1.6%
Q3 24
24.8%
Q2 24
22.9%
-9.0%
Net Margin
FTDR
FTDR
HCM
HCM
Q1 26
9.1%
Q4 25
0.2%
0.7%
Q3 25
17.2%
Q2 25
18.0%
163.8%
Q1 25
8.7%
3.7%
Q4 24
2.3%
Q3 24
18.5%
Q2 24
17.0%
8.4%
EPS (diluted)
FTDR
FTDR
HCM
HCM
Q1 26
$0.57
Q4 25
$0.03
$0.00
Q3 25
$1.42
Q2 25
$1.48
$0.52
Q1 25
$0.49
$0.01
Q4 24
$0.10
Q3 24
$1.30
Q2 24
$1.18
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FTDR
FTDR
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$603.0M
$1.4B
Total DebtLower is stronger
$1.2B
$93.2M
Stockholders' EquityBook value
$230.0M
$1.2B
Total Assets
$2.2B
$1.8B
Debt / EquityLower = less leverage
5.07×
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FTDR
FTDR
HCM
HCM
Q1 26
$603.0M
Q4 25
$566.0M
$1.4B
Q3 25
$563.0M
Q2 25
$562.0M
$1.4B
Q1 25
$506.0M
$836.1M
Q4 24
$436.0M
Q3 24
$375.0M
Q2 24
$419.0M
$802.5M
Total Debt
FTDR
FTDR
HCM
HCM
Q1 26
$1.2B
Q4 25
$1.1B
$93.2M
Q3 25
$1.2B
Q2 25
$1.2B
$93.4M
Q1 25
$1.2B
$82.8M
Q4 24
$1.2B
Q3 24
$565.0M
Q2 24
$569.0M
$82.1M
Stockholders' Equity
FTDR
FTDR
HCM
HCM
Q1 26
$230.0M
Q4 25
$242.0M
$1.2B
Q3 25
$316.0M
Q2 25
$254.0M
$1.2B
Q1 25
$198.0M
$759.9M
Q4 24
$239.0M
Q3 24
$261.0M
Q2 24
$214.0M
$740.1M
Total Assets
FTDR
FTDR
HCM
HCM
Q1 26
$2.2B
Q4 25
$2.1B
$1.8B
Q3 25
$2.2B
Q2 25
$2.2B
$1.8B
Q1 25
$2.1B
$1.3B
Q4 24
$2.1B
Q3 24
$1.2B
Q2 24
$1.2B
$1.3B
Debt / Equity
FTDR
FTDR
HCM
HCM
Q1 26
5.07×
Q4 25
4.73×
0.08×
Q3 25
3.64×
Q2 25
4.56×
0.08×
Q1 25
5.88×
0.11×
Q4 24
4.90×
Q3 24
2.16×
Q2 24
2.66×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FTDR
FTDR
HCM
HCM
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$114.0M
$3.4M
FCF MarginFCF / Revenue
25.3%
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$387.0M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FTDR
FTDR
HCM
HCM
Q1 26
Q4 25
$101.0M
$8.2M
Q3 25
$64.0M
Q2 25
$127.0M
$-72.9M
Q1 25
$124.0M
$40.3M
Q4 24
$58.0M
Q3 24
$25.0M
Q2 24
$103.0M
$-39.8M
Free Cash Flow
FTDR
FTDR
HCM
HCM
Q1 26
$114.0M
Q4 25
$95.0M
$3.4M
Q3 25
$58.0M
Q2 25
$120.0M
$-82.2M
Q1 25
$117.0M
$32.5M
Q4 24
$50.0M
Q3 24
$16.0M
Q2 24
$91.0M
$-49.9M
FCF Margin
FTDR
FTDR
HCM
HCM
Q1 26
25.3%
Q4 25
22.0%
1.2%
Q3 25
9.4%
Q2 25
19.4%
-29.6%
Q1 25
27.5%
10.0%
Q4 24
13.1%
Q3 24
3.0%
Q2 24
16.8%
-16.3%
Capex Intensity
FTDR
FTDR
HCM
HCM
Q1 26
Q4 25
1.4%
1.8%
Q3 25
1.0%
Q2 25
1.1%
3.3%
Q1 25
1.6%
2.4%
Q4 24
2.1%
Q3 24
1.7%
Q2 24
2.2%
3.3%
Cash Conversion
FTDR
FTDR
HCM
HCM
Q1 26
Q4 25
101.00×
4.21×
Q3 25
0.60×
Q2 25
1.14×
-0.16×
Q1 25
3.35×
3.38×
Q4 24
6.44×
Q3 24
0.25×
Q2 24
1.12×
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons